Shasun gets MHRA OK; Haupt invests in German plant; Yusen adds warehousing in Thailand;

> India's Shasun Pharmaceuticals passed a cGMP inspection by the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) for a formulation plant in India. Release (PDF)

> Munster, Germany-based CMO Haupt has invested €15 million ($19.8 million) in its manufacturing plant in preparation to make oral contraceptives for an unnamed client. Story

> Logistics company Yusen has opened a 40,000-square-meter warehouse in Laem Chabang, Thailand. Item

> The FDA has sent a warning letter to the Jabones Pardo plant in Madrid, Spain. Letter

> The FDA has sent a warning letter to Stewart Compounding Pharmacy in Fayetteville, NC. Letter

> India's Union Health Ministry is looking to amend rules to require drugmakers to hold records and samples longer as part of an effort to upgrade manufacturing quality. Story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.